Long-Term (5-Year) Effects of a Reduced-Fat Diet Intervention in Individuals With Glucose Intolerance

  1. Boyd A. Swinburn, MD, FRACP1,
  2. Patricia A. Metcalf, PHD1 and
  3. Sarah J. Ley, MSC1
  1. 1Department of Community Health, University of Auckland, Auckland, New Zealand

    Abstract

    OBJECTIVE—To determine whether reducing dietary fat would reduce body weight and improve long-term glycemia in people with glucose intolerance.

    RESEARCH DESIGN AND METHODS—A 5-year follow-up of a 1-year randomized controlled trial of a reduced-fat ad libitum diet versus a usual diet. Participants with glucose intolerance (2-h blood glucose 7.0–11.0 mmol/l) were recruited from a Workforce Diabetes Survey. The group that was randomized to a reduced-fat diet participated in monthly small-group education sessions on reduced-fat eating for 1 year. Body weight and glucose tolerance were measured in 136 participants at baseline, 6 months, and 1 year (end of intervention), with follow-up at 2 years (n = 104), 3 years (n = 99), and 5 years (n = 103).

    RESULTS—Compared with the control group, weight decreased in the reduced-fat–diet group (P < 0.0001); the greatest difference was noted at 1 year (–3.3 kg), diminished at subsequent follow-up (−3.2 kg at 2 years and −1.6 kg at 3 years), and was no longer present by 5 years (1.1 kg). Glucose tolerance also improved in patients on the reduced-fat diet; a lower proportion had type 2 diabetes or impaired glucose tolerance at 1 year (47 vs. 67%, P < 0.05), but in subsequent years, there were no differences between groups. However, the more compliant 50% of the intervention group maintained lower fasting and 2-h glucose at 5 years (P = 0.041 and P = 0.026, respectively) compared with control subjects.

    CONCLUSIONS—The natural history for people at high risk of developing type 2 diabetes is weight gain and deterioration in glucose tolerance. This process may be ameliorated through adherence to a reduced fat intake.

    Footnotes

    • Address correspondence and reprint requests to Boyd A. Swinburn, MD, FRACP, Professor, School of Health Sciences, Deakin University, 221 Burwood Hwy., Victoria 3125, Australia. E-mail: swinburn{at}deakin.edu.au.

      Received for publication 25 April 2000 and accepted in revised form 30 November 2000.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    « Previous | Next Article »Table of Contents